Using de-identified lab data to find patients, target physicians and expedite treatment

Sponsored content By Norstella

Lab data has become an increasingly essential dataset for pharmaceutical companies at all stages of the product life cycle. A key use case for our MMIT clients is using lab data for commercial targeting. Since lab tests often represent one of the earliest data points in a patient’s diagnostic journey, pharma companies are using lab results to identify potential patients and their physicians in time to directly impact the patient’s treatment plan. By coupling lab data with clinical expertise, pharma companies can focus on physicians who recommend and prescribe treatments for applicable patients.

I spoke to Patrick Winniewicz, executive director of Healthcare Analytics Solutions at Quest Diagnostics, about the diverse possibilities for lab data in...

Today's Sponsors

Today's Sponsor